Clinical Trial Update: Weight Based Enoxaparin in Trauma Patients [Phase 4]

View source ↗

Summary

This update describes a Phase 4 clinical trial evaluating weight-based dosing of enoxaparin in trauma patients for venous thromboembolism.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Drugs mentioned

• Lovenox (enoxaparin)

Snippet

Sponsor: Intermountain Health Care, Inc. | Conditions: Venous Thromboembolism | Phase 4 | Status: UNKNOWN